General
Preferred name
E-52862
Synonyms
E-52862 hydrochloride ()
S1RA ()
S1RA (hydrochloride) ()
S1RA hydrochloride ()
P&D ID
PD018612
CAS
878141-96-9
1265917-14-3
Tags
available
drug candidate
Drug indication
Coronavirus Disease 2019 (COVID-19)
Drug Status
investigational
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION E-52862 is a σ1 receptor antagonist . It has been shown to exert dose-dependent antinociceptive effects in several neuropathic pain models. (GtoPdb)
DESCRIPTION S1RA (E-52862) is a highly selective ¦Ò1 receptor (¦Ò1R) antagonist with Kis of 17 nM and 23.5 nM for human ¦Ò1R and guinea pig ¦Ò1R, respectively. S1RA has Moderate antagonistic activity for human 5-HT2B receptor (Ki= 328 nM). S1RA has antinociceptive effects in neuropathic pain models. S1RA prevents mechanical and cold hypersensitivity in Oxaliplatin (HY-17371)-treated mice[1][2].
PRICE 94
DESCRIPTION S1RA (E-52862)(E-52862) is a potent, selective antagonist of the sigma-1 receptor (??1R, Ki=17 nM), demonstrating significant selectivity over the sigma-2 receptor (??2R, Ki > 1000 nM).
DESCRIPTION S1RA (E-52862) hydrochloride is an orally active and selective sigma-1 receptor (¦Ò1R) antagonist with a Ki value of 17 nM. S1RA hydrochloride shows good selectivity against ¦Ò2R (Ki >1000 nM). S1RA hydrochloride is a human 5-HT2B receptor antagonist with an IC50 value of 4.7 ¦ÌM. S1RA hydrochloride inhibits neuropathic pain and activity-induced spinal sensitization[1][2].
PRICE 92
DESCRIPTION S1RA hydrochloride (E-52862 hydrochloride) is an effective and specific sigma-1 receptor(??1R, Ki: 17 nM) antagonist, and has good selectivity against ??2R (Ki > 1000 nM).
DESCRIPTION The sigma-1 (σ1) receptor is an intracellular, non-opioid receptor that is abundantly expressed in the central nervous system as well as peripherally. S1RA is a potent, selective antagonist of σ1 receptors (Ki = 17 nM) that weakly binds σ2 receptors (Ki = 9,300 nM). (BOC Sciences Bioactive Compounds)
DESCRIPTION S1RA (E-52862)(E-52862) is a potent, selective antagonist of the sigma-1 receptor (σ1R, Ki=17 nM), demonstrating significant selectivity over the sigma-2 receptor (σ2R, Ki > 1000 nM). (TargetMol Bioactive Compound Library)
DESCRIPTION The hydrochloride salt form of S1RA which is a σ1 receptor antagonist that has been found to have potential effect in pain therapy. It is still under Phase II clinical trial. IC50: 17 nM (Ki). (BOC Sciences Bioactive Compounds)
DESCRIPTION S1RA hydrochloride (E-52862 hydrochloride) is an effective and specific sigma-1 receptor(σ1R, Ki: 17 nM) antagonist, and has good selectivity against σ2R (Ki > 1000 nM). (TargetMol Bioactive Compound Library)
Compound Sets
11
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
DrugMAP
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
337.18
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
3
cLogP
3.04
TPSA
39.52
Fraction CSP3
0.35
Chiral centers
0.0
Largest ring
6.0
QED
0.72
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Sigma Receptor
σ1
σ2
SIGMAR1
5-HT Receptor
MOA
Sigma receptor antagonist
Therapeutic Class
Antiviral Agents
Pathway
GPCR/G protein
Neuronal Signaling
Solubility
DMSO:≥ 57 mg/mL
Source data